Kyung Jin Chung
No ORCID on file
· 1 paper in corpus
review
2017
New drug development is a high-risk venture, but if successful, will bring great revenues to those willing to accept the risk. In the field of urology, in particular for lower urinary tract symptoms (LUTS), the recent successful landing of …